GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » EV-to-Revenue

Cantourage Group SE (XTER:HIGH) EV-to-Revenue : 0.00 (As of Jun. 25, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cantourage Group SE's enterprise value is €0.00 Mil. Cantourage Group SE's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €1.20 Mil. Therefore, Cantourage Group SE's EV-to-Revenue for today is 0.00.

The historical rank and industry rank for Cantourage Group SE's EV-to-Revenue or its related term are showing as below:

XTER:HIGH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -0.98

XTER:HIGH's EV-to-Revenue is ranked worse than
100% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 2.16 vs XTER:HIGH: -0.98

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-25), Cantourage Group SE's stock price is €7.00. Cantourage Group SE's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.00. Therefore, Cantourage Group SE's PS Ratio for today is .


Cantourage Group SE EV-to-Revenue Historical Data

The historical data trend for Cantourage Group SE's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE EV-to-Revenue Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-Revenue
- - - -

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
EV-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of Cantourage Group SE's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's EV-to-Revenue falls into.



Cantourage Group SE EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cantourage Group SE's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.000/1.202
=0.00

Cantourage Group SE's current Enterprise Value is €0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cantourage Group SE's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €1.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantourage Group SE  (XTER:HIGH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cantourage Group SE's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=7.00/
=

Cantourage Group SE's share price for today is €7.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantourage Group SE EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE (XTER:HIGH) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines